A study found that treatment with CXCL12 prompted CTLs to leave cutaneous tumors via lymphatic vessels (137), whereas suppression of CXCL12 expression in senescent tumor cells enhanced T cell infiltration in colonic tumors (138). This evidence concerns the gene CXCL12 and colonic neoplasm.